These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 18759921)

  • 1. Negative signaling by inhibitory receptors: the NK cell paradigm.
    Long EO
    Immunol Rev; 2008 Aug; 224():70-84. PubMed ID: 18759921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk.
    Peterson ME; Long EO
    Immunity; 2008 Oct; 29(4):578-88. PubMed ID: 18835194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstitution of killer cell inhibitory receptor-mediated signal transduction machinery in a cell-free model system.
    Cho HI; Park CG; Kim J
    Arch Biochem Biophys; 1999 Aug; 368(2):221-31. PubMed ID: 10441372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells.
    Joncker NT; Raulet DH
    Immunol Rev; 2008 Aug; 224():85-97. PubMed ID: 18759922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell immunotherapy for cancer: a new hope.
    Srivastava S; Lundqvist A; Childs RW
    Cytotherapy; 2008; 10(8):775-83. PubMed ID: 19089686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells.
    Lanier LL; Corliss BC; Wu J; Leong C; Phillips JH
    Nature; 1998 Feb; 391(6668):703-7. PubMed ID: 9490415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular signaling by the killer immunoglobulin-like receptors and Ly49.
    McVicar DW; Burshtyn DN
    Sci STKE; 2001 Mar; 2001(75):re1. PubMed ID: 11752646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
    Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
    J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential.
    Faure M; Long EO
    J Immunol; 2002 Jun; 168(12):6208-14. PubMed ID: 12055234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias.
    Moretta A; Locatelli F; Moretta L
    Immunol Rev; 2008 Aug; 224():58-69. PubMed ID: 18759920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules.
    Sleiman M; Brons NH; Kaoma T; Dogu F; Villa-Forte A; Lenoble P; Hentges F; Kotsch K; Gadola SD; Vilches C; Zimmer J
    J Immunol; 2014 Mar; 192(6):2602-10. PubMed ID: 24554773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory receptors signal activation.
    Yokoyama WM
    Immunity; 2008 Oct; 29(4):515-7. PubMed ID: 18957262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling natural killer cell responses: integration of signals for activation and inhibition.
    Long EO; Kim HS; Liu D; Peterson ME; Rajagopalan S
    Annu Rev Immunol; 2013; 31():227-58. PubMed ID: 23516982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA Class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2A-expressing transfectant.
    Lin Chua H; Brahmi Z
    Cell Immunol; 2002 Sep; 219(1):57-70. PubMed ID: 12473268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cell cytotoxicity and its regulation by inhibitory receptors.
    Kumar S
    Immunology; 2018 Jul; 154(3):383-393. PubMed ID: 29512837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors.
    Ortaldo JR; Winkler-Pickett R; Willette-Brown J; Wange RL; Anderson SK; Palumbo GJ; Mason LH; McVicar DW
    J Immunol; 1999 Nov; 163(10):5269-77. PubMed ID: 10553049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex.
    Campbell KS; Cella M; Carretero M; López-Botet M; Colonna M
    Eur J Immunol; 1998 Feb; 28(2):599-609. PubMed ID: 9521070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells.
    Yusa S; Campbell KS
    J Immunol; 2003 May; 170(9):4539-47. PubMed ID: 12707331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ap-2 clathrin adaptor mediates endocytosis of an inhibitory killer cell Ig-like receptor in human NK cells.
    Purdy AK; Alvarez Arias DA; Oshinsky J; James AM; Serebriiskii I; Campbell KS
    J Immunol; 2014 Nov; 193(9):4675-83. PubMed ID: 25238755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.